Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced
Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations
in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
Does the drug Palbociclib help treat patients with with tumors?
Basic Study Information
Purpose:Location: University of Rochester
This phase II Pediatric MATCH trial studies how well palbociclib works in treating
with Rb positive solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with
alterations (mutations) in cell cycle genes that have spread to other places in the
have come back or do not respond to treatment. Palbociclib may stop the growth of
cells by blocking some of the enzymes needed for cell growth.
Lead Researcher (Principal Investigator)
Lead Researcher: Angela Girvin
Study Contact InformationPhone: (585) 275-5830
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search